Shahid Ghazi Pharmaceutical Company (DGHAZI) cash flow statement
Operating, investing and financing cash flows, and the closing balance
- Ticker
- DGHAZI
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Cash generated from operations | 2,970,961 | -564,480 | 2,431,461 | 3,090,585 | 1,519,276 | 1,129,408 |
| Cash payments for income tax | -85,733 | -274,284 | -758,219 | -453,127 | -194,484 | 0 |
| Net cash inflow (outflow) from operating activities | 2,885,228 | -838,764 | 1,673,242 | 2,637,458 | 1,324,792 | 1,129,408 |
| Cash payments for purchase of property, plant and equipment | -640,640 | -378,990 | -390,582 | -704,995 | -367,677 | -355,821 |
| Cash receipts from dividends | 88,807 | 0 | 18 | 27 | 20 | 517 |
| Cash receipts from interest on other investments | 127 | 32 | 164 | 81 | 86 | 789 |
| Net cash inflow (outflow) from investing activities | -551,706 | -382,808 | -390,400 | -705,432 | -367,571 | -354,515 |
| Net cash inflow (outflow) before financing activities | 2,333,522 | -1,221,572 | 1,282,842 | 1,932,026 | 957,221 | 774,893 |
| Cash receipts from capital increase | 4,154 | 0 | 0 | 0 | 51 | 3,126 |
| Cash receipts from sale of treasury shares | 67,041 | 7,121 | 0 | 48,646 | 25,536 | 36,523 |
| Cash payments for purchase of treasury shares | -85,180 | -5,496 | -1,376 | -50,864 | -32,378 | -49,058 |
| Cash receipts from facilities | 13,449,980 | 4,527,486 | 1,931,459 | 2,908,346 | 2,105,502 | 708,500 |
| Cash payments for principal of loans | -8,862,859 | -1,917,769 | -2,443,706 | -2,850,859 | -2,044,831 | -766,563 |
| Cash payments for interest on loans | -463,781 | -183,234 | -451,131 | -274,062 | -265,389 | -82,365 |
| Cash payments for interest on participation bonds | -1,205,100 | -494,453 | 0 | 0 | 0 | 0 |
| Cash payments for dividends | -3,294,615 | -304,765 | -1,144,019 | -969,909 | -715,340 | -701,712 |
| Net cash inflow (outflow) from financing activities | -390,360 | 1,628,890 | -2,108,773 | -1,188,702 | -926,849 | -851,549 |
| Net increase (decrease) in cash | 1,943,162 | 407,318 | -825,931 | 743,324 | 30,372 | -76,656 |
| Cash balance at beginning of year | 901,813 | 1,064,251 | 1,032,702 | 191,954 | 310,029 | 587,215 |
| Effect of changes in exchange rates | 87,941 | 6,815 | 8,772 | 162 | 18,122 | 26,516 |
| Cash balance at end of year | 2,932,916 | 1,478,384 | 215,543 | 935,440 | 358,523 | 537,075 |
Reporting periods
44 periods are on file for this report, from the period ending 1393/06/31 to the period ending 1405/06/31.